Skip to main content
Erschienen in: Clinical Rheumatology 2/2016

01.02.2016 | Brief Report

PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists

verfasst von: Luca Cantarini, Antonio Vitale, Giulia Bersani, Laura Martin Nieves, Marco Cattalini, Giuseppe Lopalco, Francesco Caso, Luisa Costa, Florenzo Iannone, Giovanni Lapadula, Mauro Galeazzi, Angela Ceribelli, Enrico Brunetta, Carlo Selmi, Donato Rigante

Erschienen in: Clinical Rheumatology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

The pediatric syndrome characterized by periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and adult Behçet’s disease share some clinical manifestations and are both polygenic autoinflammatory disorders with interleukin-1β showing to play a pivotal role. However, the diagnosis is mostly clinical and we hypothesize that specific criteria may be addressed differently by different physicians. To determine the diagnostic variability, we compared the answers of 80 patients with a definite diagnosis of Behçet’s disease (age 42.1 ± 13.7 years) obtained by separate telephone interviews conducted by a rheumatologist, a pediatrician, and an internist working largely in the field of autoinflammatory disorders. Questions were related to the age of symptom onset, the occurrence of recurrent fevers during childhood, and the association with oral aphthosis, cervical adenitis and/or pharyngitis, previous treatments, possible growth impairment, the time lapse between PFAPA-like symptoms and the onset of Behçet’s disease, and the occurrence of Behçet-related manifestation during childhood. The rheumatologist identified 30 % of patients with Behçet’s disease fulfilling PFAPA syndrome diagnostic criteria, compared to the pediatrician and the internist identifying 10 and 7.5 %, respectively. Most of the patients suffered from recurrent oral aphthosis in childhood also without fever (50, 39, and 48 % with each interviewer), yet no patient fulfilled the Behçet’s disease diagnostic criteria. Our data suggest that physician awareness and expertise are central to the diagnosis of autoinflammatory disorders through an accurate collection of the medical history.
Literatur
1.
Zurück zum Zitat Marshall GS, Edwards KM, Butler J, Lawton AR (1987) Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 110:43–46CrossRefPubMed Marshall GS, Edwards KM, Butler J, Lawton AR (1987) Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 110:43–46CrossRefPubMed
2.
Zurück zum Zitat Rigante D (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev 11:348–356CrossRefPubMed Rigante D (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev 11:348–356CrossRefPubMed
3.
Zurück zum Zitat Stojanov S, Lapidus S, Chitkara P et al (2011) Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A 108:7148–7153PubMedCentralCrossRefPubMed Stojanov S, Lapidus S, Chitkara P et al (2011) Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A 108:7148–7153PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Kolly L, Busso N, von Scheven-Gete A et al (2013) Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1β production. J Allergy Clin Immunol 131:1635–1643CrossRefPubMed Kolly L, Busso N, von Scheven-Gete A et al (2013) Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1β production. J Allergy Clin Immunol 131:1635–1643CrossRefPubMed
5.
6.
Zurück zum Zitat Thomas KT, Feder HM Jr, Lawton AR, Edwards KM (1999) Periodic fever syndrome in children. J Pediatr 135:15–21CrossRefPubMed Thomas KT, Feder HM Jr, Lawton AR, Edwards KM (1999) Periodic fever syndrome in children. J Pediatr 135:15–21CrossRefPubMed
7.
Zurück zum Zitat Cantarini L, Vitale A, Bartolomei B, Galeazzi M, Rigante D (2012) Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers. Clin Exp Rheumatol 30:269–271PubMed Cantarini L, Vitale A, Bartolomei B, Galeazzi M, Rigante D (2012) Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers. Clin Exp Rheumatol 30:269–271PubMed
8.
Zurück zum Zitat Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358–360PubMed Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358–360PubMed
9.
Zurück zum Zitat Padeh S, Brezniak N, Zemer D et al (1999) Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 135:98–101CrossRefPubMed Padeh S, Brezniak N, Zemer D et al (1999) Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 135:98–101CrossRefPubMed
10.
Zurück zum Zitat Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83CrossRefPubMed Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83CrossRefPubMed
11.
Zurück zum Zitat Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566CrossRefPubMed Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566CrossRefPubMed
12.
Zurück zum Zitat Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R (2012) Successful use of canakinumab in a patient with resistant Behçet's disease. Clin Exp Rheumatol 30:S115PubMed Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R (2012) Successful use of canakinumab in a patient with resistant Behçet's disease. Clin Exp Rheumatol 30:S115PubMed
13.
Zurück zum Zitat Vitale A, Rigante D, Caso F et al (2014) Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology 228:211–214CrossRefPubMed Vitale A, Rigante D, Caso F et al (2014) Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology 228:211–214CrossRefPubMed
14.
Zurück zum Zitat Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R et al (2013) Anakinra treatment in drug-resistant Behçet's disease: a case series. Clin Rheumatol. doi:10.1007/s10067-013-2443-8 PubMed Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R et al (2013) Anakinra treatment in drug-resistant Behçet's disease: a case series. Clin Rheumatol. doi:10.​1007/​s10067-013-2443-8 PubMed
15.
Zurück zum Zitat Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A (1995) Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity. Isr J Med Sci 31:345–348PubMed Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A (1995) Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity. Isr J Med Sci 31:345–348PubMed
16.
Zurück zum Zitat Zou J, Guan JL (2014) Interleukin-1-related genes polymorphisms in Turkish patients with Behçet disease: a meta-analysis. Mod Rheumatol 24:321–326CrossRefPubMed Zou J, Guan JL (2014) Interleukin-1-related genes polymorphisms in Turkish patients with Behçet disease: a meta-analysis. Mod Rheumatol 24:321–326CrossRefPubMed
17.
Zurück zum Zitat International Study Group for Behçet disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
18.
Zurück zum Zitat Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Behçet's disease. Autoimmun Rev 11:699–704CrossRefPubMed Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Behçet's disease. Autoimmun Rev 11:699–704CrossRefPubMed
19.
Zurück zum Zitat Pineton de Chambrun M, Wechsler B, Geri G et al (2012) New insights into the pathogenesis of Behcet's disease. Autoimmun Rev 11:687–698CrossRefPubMed Pineton de Chambrun M, Wechsler B, Geri G et al (2012) New insights into the pathogenesis of Behcet's disease. Autoimmun Rev 11:687–698CrossRefPubMed
21.
Zurück zum Zitat Esposito S, Bianchini S, Fattizzo M et al (2014) The enigma of periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Pediatr Infect Dis J 33:650–652CrossRefPubMed Esposito S, Bianchini S, Fattizzo M et al (2014) The enigma of periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Pediatr Infect Dis J 33:650–652CrossRefPubMed
22.
Zurück zum Zitat Federici L, Rittore-Domingo C, Koné-Paut I et al (2006) A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 65:1427–1432PubMedCentralCrossRefPubMed Federici L, Rittore-Domingo C, Koné-Paut I et al (2006) A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 65:1427–1432PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373CrossRefPubMed Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373CrossRefPubMed
25.
Zurück zum Zitat Hofer M, Pillet P, Cochard MM et al (2014) International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford) 53:1125–1129CrossRef Hofer M, Pillet P, Cochard MM et al (2014) International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford) 53:1125–1129CrossRef
Metadaten
Titel
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists
verfasst von
Luca Cantarini
Antonio Vitale
Giulia Bersani
Laura Martin Nieves
Marco Cattalini
Giuseppe Lopalco
Francesco Caso
Luisa Costa
Florenzo Iannone
Giovanni Lapadula
Mauro Galeazzi
Angela Ceribelli
Enrico Brunetta
Carlo Selmi
Donato Rigante
Publikationsdatum
01.02.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 2/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2890-5

Weitere Artikel der Ausgabe 2/2016

Clinical Rheumatology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.